drugset / Trial / NCT03443128
Vinorelbine for Recurrent ALCL-2017
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the efficiency and safety of vinorelbine in the treatment of relapsed / advanced ALCL in children and adolescents.
Timeline
- Start
- 2016-11
- Primary completion
- 2024-12
- Completion
- 2025-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vinorelbine | Small molecule | 25 mg/m2 | — |